Goldman Sachs’s Nephros NEPH Stock Holding History
Bought
Maintained
Sold
Other funds holding NEPH
Goldman Sachs's NEPH Position: Q3 2026 in Review
Goldman Sachs reduced its Nephros (NEPH) stake by 7.2% in Q3 2026, selling an estimated $3.7K and leaving 11,908 shares worth $44.2K. The position accounts for ﹤0.01% of the portfolio, ranked #6449.
Goldman Sachs first reported a position in NEPH in Q3 2019 and has held it in 6 quarters since. The position peaked at $156K in Q3 2019. 36 funds tracked by Wall St. Rank hold NEPH as of Q3 2026.
- Goldman Sachs held 11,908 shares of Nephros worth $44.2K as of Q3 2026.
- Goldman Sachs sold 928 Nephros shares in Q3 2026, an estimated $3.7K.
- Nephros made up ﹤0.01% of Goldman Sachs's portfolio in Q3 2026, its #6449 holding.
- Goldman Sachs first reported a position in Nephros in Q3 2019 and has held it in 6 quarters since.
- Goldman Sachs's Nephros position peaked at $156K in Q3 2019.
- 36 funds tracked by Wall St. Rank held Nephros as of Q3 2026.
Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.